Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added study locations in Ohio and Pennsylvania and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the previous Ohio and Pennsylvania location entries.
    Difference
    0.2%
    Check dated 2025-12-24T14:28:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Publications are described as auto-filled from PubMed, and the page revision was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:02.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page no longer displays a site-wide government funding/operating status notice, which does not affect the trial data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:35:51.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Results for the RELIVE study have been posted on the page, and the Study Record Dates now show a Results First Posted date of 2021-06-02.
    Difference
    0.2%
    Check dated 2025-10-27T21:11:36.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 release; removal of the old v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-06T08:44:18.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T07:32:14.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.